FREE Account Opening + No Clearing Fees

Ambey Laboratories Limited IPO (Ambey Laboratories IPO) Detail

July 4, 2024 - July 8, 2024

Ambey Laboratories IPO is a book built issue of Rs 44.68 crores. The issue is a combination of fresh issue of 62.58 lakh shares aggregating to Rs 42.55 crores and offer for sale of 3.12 lakh shares aggregating to Rs 2.12 crores.

Ambey Laboratories IPO bidding started from July 4, 2024 and ended on July 8, 2024. The allotment for Ambey Laboratories IPO was finalized on Tuesday, July 9, 2024. The shares got listed on NSE SME on July 11, 2024.

Ambey Laboratories IPO price band is set at ₹65 to ₹68 per share. The minimum lot size for an application is 2000 Shares. The minimum amount of investment required by retail investors is ₹136,000. The minimum lot size investment for HNI is 2 lots (4,000 shares) amounting to ₹272,000.

Fast Track Finsec Pvt Ltd is the book running lead manager of the Ambey Laboratories IPO, while Link Intime India Private Ltd is the registrar for the issue. The market maker for Ambey Laboratories IPO is Nikunj Stock Brokers.

Refer to Ambey Laboratories IPO RHP for detailed information.

Ambey Laboratories IPO Details

IPO Date July 4, 2024 to July 8, 2024
Listing Date July 11, 2024
Face Value ₹10 per share
Price Band ₹65 to ₹68 per share
Lot Size 2000 Shares
Total Issue Size6,570,000 shares
(aggregating up to ₹44.68 Cr)
Fresh Issue6,258,000 shares
(aggregating up to ₹42.55 Cr)
Offer for Sale312,000 shares of ₹10
(aggregating up to ₹2.12 Cr)
Issue Type Book Built Issue IPO
Listing At NSE SME
Share holding pre issue18,688,819
Share holding post issue25,258,819
Market Maker portion330,000 shares
Nikunj Stock Brokers

Ambey Laboratories IPO Reservation

Ambey Laboratories IPO offers 6,244,001 shares. 1,252,000 (20.05%) to QIB, 606,001 (9.71%) to NII, 2,184,000 (34.98%) to RII and 1,872,000 (29.98%) to Anchor investors.

Investor Category Shares Offered
Anchor Investor Shares Offered1,872,000 (29.98%)
Market Maker Shares Offered330,000 (5.29%)
QIB Shares Offered1,252,000 (20.05%)
NII (HNI) Shares Offered606,001 (9.71%)
Retail Shares Offered2,184,000 (34.98%)
Total Shares Offered6,244,001 (100%)

Ambey Laboratories IPO Anchor Investors Details

Ambey Laboratories IPO raises Rs 12.73 crore from anchor investors. Ambey Laboratories IPO Anchor bid date is July 3, 2024. Ambey Laboratories IPO Anchor Investors list

Bid Date July 3, 2024
Shares Offered 1,872,000
Anchor Portion Size (In Cr.) 12.73
Anchor lock-in period end date for 50% shares (30 Days) August 8, 2024
Anchor lock-in period end date for remaining shares (90 Days) October 7, 2024

Ambey Laboratories IPO Timeline (Tentative Schedule)

Ambey Laboratories IPO opens on July 4, 2024, and closes on July 8, 2024.

IPO Open Date Thursday, July 4, 2024
IPO Close Date Monday, July 8, 2024
Basis of Allotment Tuesday, July 9, 2024
Initiation of Refunds Wednesday, July 10, 2024
Credit of Shares to Demat Wednesday, July 10, 2024
Listing Date Thursday, July 11, 2024
Cut-off time for UPI mandate confirmation 5 PM on July 8, 2024

Ambey Laboratories IPO Lot Size

Investors can bid for a minimum of 2000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 2000 ₹136,000
Retail (Max) 1 2000 ₹136,000
HNI (Min) 2 4,000 ₹272,000
Lot Size Calculator

Ambey Laboratories IPO Promoter Holding

The promoters of the company are Archit Gupta, Arpit Gupta, Sarina Gupta and Rishita Gupta.

Share Holding Pre Issue 94.97%
Share Holding Post Issue 69.90%

About Ambey Laboratories Limited

Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.

The company manufactures and supplies 2,4-D base chemicals.

The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation.

The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd:

  • 2,4-D Acid 98% TC
  • 2,4-D Sodium 95% SP
  • 2,4-D Amine 866 | 720 | 480g/l SL
  • 2,4-D Ethyl Hexyl Ester 96% TC
  • 2,4-D Ethyl Ester 96% TC
  • Chlorpyriphos 97%TC / 20%EC / 50%EC
  • Thiamethoxam 96%TC / 25%WG / 75%SG
  • Pretilachlor 95%TC / 50%EC / 37%EW
  • Metribuzin 97%TC / 70%WS
  • Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC
  • Metalaxyl 98%TC / 35%WS

 As of October 31, 2023 the company employs 220 people in various departments.

Ambey Laboratories Limited Financial Information (Restated)

Period Ended31 Jan 202431 Mar 202331 Mar 202231 Mar 2021
Profit After Tax607.73456.93357.471,033.67
Net Worth3,431.342,363.601,906.67-786.39
Reserves and Surplus1,562.46588.66131.73-1,275.74
Total Borrowing2,005.441,365.221,804.863,292.98
Amount in ₹ Lakhs

Key Performance Indicator

The market capitalization of Ambey Laboratories IPO is Rs 171.64 Cr.

KPI as of January 31, 2024.

KPI Values
PAT Margin (%)6.01
Pre IPO Post IPO
EPS (Rs) 2.442.89
P/E (x) 27.8123.54
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2023 that is available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of January 31, 2024 that is available in RHP.

Objects of the Issue (Ambey Laboratories IPO Objectives)

The company intends to utilize the Net Proceeds for the following objects:

  • To meet Working Capital Requirements
  • General corporate purposes
  • Issue related expenses

Ambey Laboratories IPO Review (Avoid)

[Dilip Davda]  The company is operating in a highly competitive and fragmented segment of agrochemicals. It has posted inconsistency in its bottom lines for the reported periods. There is some garble in the offer documents on financial data. Based on FY24 annualized super earnings, the issue appears aggressively priced discounting all near term positives. There is no harm in skipping this “High Risk/Low Return” bet. Read detail review...

Ambey Laboratories IPO Subscription Status (Bidding Detail)

The Ambey Laboratories IPO is subscribed 173.18 times on July 8, 2024 6:19:58 PM. The public issue subscribed 195.06 times in the retail category, 61.90 times in the QIB category, and 324.22 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Total Application : 213,007 (195.06 times)

Ambey Laboratories IPO Prospectus

Ambey Laboratories IPO Rating

Rating:Rated 4.0 stars
Vote Here ...

Ambey Laboratories IPO Listing Details

Listing Date July 11, 2024
BSE Script Code
Final Issue Price ₹68 per share

Pre-Open Session - NSE

Listing Day Trading Information

Price Details
Final Issue Price
Last Trade

Check IPO Performance…

Ambey Laboratories Limited Contact Details

Ambey Laboratories Limited
Ground Floor, Property No.555 Tarla Mohalla,
Ghitorni, West Delhi
New Delhi, -110030
Phone: 0124-4000788

Ambey Laboratories IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

Ambey Laboratories IPO - Buy or Not

Ambey Laboratories IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 0 0 1
Members 0 0 0

Read All Reviews Post Your Review Manage Reviews

SME IPO Enquiry

SME Company Owners
We could help you get listed on the stock market.

Contact us Today

Check our SME IPO Guide New

Ambey Laboratories IPO FAQs

Ambey Laboratories IPO is a SME IPO of 6,570,000 equity shares of the face value of ₹10 aggregating up to ₹44.68 Crores. The issue is priced at ₹65 to ₹68 per share. The minimum order quantity is 2000 Shares.

The IPO opens on July 4, 2024, and closes on July 8, 2024.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

Zerodha customers can apply online in Ambey Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Ambey Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.

Steps to apply in Ambey Laboratories IPO through Zerodha

  1. Visit the Zerodha website and login to Console.
  2. Go to Portfolio and click the IPOs link.
  3. Go to the 'Ambey Laboratories IPO' row and click the 'Bid' button.
  4. Enter your UPI ID, Quantity, and Price.
  5. ‘Submit’ IPO application form.
  6. Visit the UPI App (net banking or BHIM) to approve the mandate.

Visit Zerodha IPO Application Process Review for more detail.

The Ambey Laboratories IPO opens on July 4, 2024 and closes on July 8, 2024.

Ambey Laboratories IPO lot size is 2000 Shares, and the minimum amount required is ₹136,000.

You can apply in Ambey Laboratories IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Ambey Laboratories IPO will be done on Tuesday, July 9, 2024, and the allotted shares will be credited to your demat account by Wednesday, July 10, 2024. Check the Ambey Laboratories IPO allotment status.

The Ambey Laboratories IPO listing date is on July 11, 2024.
Open an Instant Account with Zerodha

Ambey Laboratories IPO Message Board

Ranked Members of Forum  Ranked Members | Members with Most Likes